SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RELATED MATTERS (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	May 31, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2009
Research and development		$ 8,000	$ 52,000
Accumulated deficit		(69,195,000)	(67,973,000)
Working capital deficit		(1,520,000)
NET INCOME (LOSS)		(1,222,000)	(8,334,000)
Proceeds from sale of assets held for sale	$ 300,000	300,000	500,000
Cash FDIC insured amount		$ 250,000
Sale of asset			$ 1,200,000
Proceeds from sale of asset description		The remaining $900,000 will be collected during the next three years in equal increments on the anniversary date of the agreement, May 1.
Income Tax Examination, Likelihood of Unfavorable Settlement		An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.
Stock Option [Member]
Weighted average number diluted shares		22,075,000	21,605,000
Warrants [Member]
Weighted average number diluted shares		9,700,000	28,943,182
Preferred Stock [Member]
Weighted average number diluted shares		13,549,177	13,549,177
Imagion Biosystems, Inc., [Member]
Issued and outstanding shares noncontrolling interest		12.00%	19.00%
Los Alamos National Security LLC [Member] | Patent license agreement [Member]
Annual license fee				$ 10,000